CTOs on the Move

Proprio Vision

www.propriovision.com

 
Proprio is a Seattle company developing a system for real-time immersive video and mediated reality interaction. We are using cutting edge algorithms and custom hardware to enhance human capabilities in high precision activities such as brain surgery.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Proprio Vision raised $23M on 09/05/2020

Similar Companies

OLLY PBC

At OLLY, we believe happiness is an inside job. We know that the right blend of nutrients can help us stay strong, balanced and energetic.

Upswing Health

Upswing helps you #getbackintheswing of things. We help athletes identify injuries and find the best path to recovery.

Ameronc Inc

Ameronc Inc is a Birmingham, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Baxalta

Newly combined with Baxalta, Shire is now the leading global biotechnology company focused on serving people affected by rare diseases and highly specialized conditions. These diseases are often misunderstood, under-diagnosed, and potentially life-threatening. Our 22,000 employees come to work every day with a common purpose: to develop and deliver breakthrough therapies that enable people with life-altering conditions to live their lives to the fullest. At Shire, we are dedicated to expanding, building and sustaining leadership across our key therapeutic areas through our extensive portfolio of products, innovative pipeline and collaborative approach to working with diverse partners around the globe. We strive to earn and keep the trust of our patients, their families and physicians, and all others who support and advance their care. Working together, the possibilities for our patients, healthcare partners and employees are unprecedented, with significant growth potential for our shareholders.

Governance Institute, The

Governance Institute, The is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.